CL2023001779A1 - Composiciones de cannabidiol y usos de las mismas - Google Patents
Composiciones de cannabidiol y usos de las mismasInfo
- Publication number
- CL2023001779A1 CL2023001779A1 CL2023001779A CL2023001779A CL2023001779A1 CL 2023001779 A1 CL2023001779 A1 CL 2023001779A1 CL 2023001779 A CL2023001779 A CL 2023001779A CL 2023001779 A CL2023001779 A CL 2023001779A CL 2023001779 A1 CL2023001779 A1 CL 2023001779A1
- Authority
- CL
- Chile
- Prior art keywords
- compositions
- cannabidiol
- cannabidiol compositions
- relates
- ibh
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 title abstract 2
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 title abstract 2
- 229950011318 cannabidiol Drugs 0.000 title abstract 2
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 title abstract 2
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 title abstract 2
- 230000003449 preventive effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La presente invención se refiere al uso de cannabidiol y composiciones del mismo como agente preventivo y curativo para IBH. La invención se refiere además a procedimientos y composiciones relacionados.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20217100.5A EP4019014A1 (en) | 2020-12-23 | 2020-12-23 | Cannabidiol compositions and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2023001779A1 true CL2023001779A1 (es) | 2023-11-10 |
Family
ID=73857152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2023001779A CL2023001779A1 (es) | 2020-12-23 | 2023-06-16 | Composiciones de cannabidiol y usos de las mismas |
Country Status (6)
| Country | Link |
|---|---|
| EP (2) | EP4019014A1 (es) |
| AU (1) | AU2021405708A1 (es) |
| CA (1) | CA3202981A1 (es) |
| CL (1) | CL2023001779A1 (es) |
| MX (1) | MX2023007479A (es) |
| WO (1) | WO2022136541A1 (es) |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105764504A (zh) * | 2013-09-26 | 2016-07-13 | 罗纳德·D·塞库拉 | 引入大麻种衍生的植物药品的局部治疗 |
| EP3743054A4 (en) * | 2018-01-24 | 2021-11-10 | Botanix Pharmaceuticals Ltd | CANNABINOID DOSAGE REGIME FOR DERMATITIS AND INFLAMMATORY SKIN DISORDERS |
| WO2020180969A1 (en) * | 2019-03-05 | 2020-09-10 | Colleen Smith | Veterinary compositions and methods of use therefor |
| CA3077541A1 (en) * | 2019-04-01 | 2020-10-01 | Canopy Growth Corporation | Methods and compositions for treatment of anxiety in animals |
| US20200376156A1 (en) * | 2019-05-29 | 2020-12-03 | Precision Biologics | Methods of accelerating wound healing using cannabinoid compositions |
| CN110269839A (zh) * | 2019-06-15 | 2019-09-24 | 云南飞久逍科技有限公司 | 一种大麻二酚cbd及其纳米乳在荨麻疹或/和鼻炎制剂中的应用 |
| JP2022549491A (ja) * | 2019-09-23 | 2022-11-25 | ダーマケア－ヴェット ピーティーワイ リミテッド | 医薬化合物および使用方法 |
| EP4054547A4 (en) * | 2019-11-08 | 2024-03-27 | Portland Tech Holdings Llc | HEMP EXTRACT AND METHOD OF USE THEREOF |
-
2020
- 2020-12-23 EP EP20217100.5A patent/EP4019014A1/en not_active Withdrawn
-
2021
- 2021-12-22 WO PCT/EP2021/087276 patent/WO2022136541A1/en active Application Filing
- 2021-12-22 EP EP21836211.9A patent/EP4267119A1/en active Pending
- 2021-12-22 MX MX2023007479A patent/MX2023007479A/es unknown
- 2021-12-22 AU AU2021405708A patent/AU2021405708A1/en active Pending
- 2021-12-22 CA CA3202981A patent/CA3202981A1/en active Pending
-
2023
- 2023-06-16 CL CL2023001779A patent/CL2023001779A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022136541A1 (en) | 2022-06-30 |
| MX2023007479A (es) | 2023-08-11 |
| EP4019014A1 (en) | 2022-06-29 |
| CA3202981A1 (en) | 2022-06-30 |
| EP4267119A1 (en) | 2023-11-01 |
| AU2021405708A1 (en) | 2023-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2019002255A1 (es) | 2-heteroaril-3-oxo-2,3-dihidropiridazin-4-carboxamidas. | |
| CL2017002650A1 (es) | Compuestos novedosos | |
| NI201900041A (es) | 1, 2, 4-triazolonas 2, 4, 5-trisustituidas | |
| CL2020001312A1 (es) | Composiciones de cannabidiol y usos de las mismas. (divisional solicitud 201803425). | |
| CO2018005361A2 (es) | Formulaciones inyectables de toxina botulínica y sus métodos de uso que poseen efecto terapéutico o cosmético de larga duración | |
| CL2020000632A1 (es) | Composición y método para el tratamiento del autismo. | |
| BRPI0925036B8 (pt) | uso de trans-t-butil ciclo-hexanol, composição cosmética, medicamento, seus usos e processos para tratar irritação na pele | |
| BR112018071831A2 (pt) | composições anti-irritantes sinérgicas de taurina e aloé e métodos | |
| ECSP20008441A (es) | Dihidrooxadiazinonas | |
| BR112017024013A2 (pt) | composições compreendendo células tronco mesenquimatosas e seus usos | |
| SV2017005466A (es) | Pirazolpiridinaminas como inhibidores de mknk1 y mknk2 | |
| CL2021000938A1 (es) | Composiciones estables de semaglutida y usos de las mismas | |
| ECSP21030482A (es) | Derivados de piridinil sulfonamida, composiciones farmacéuticas y usos de estos | |
| DOP2020000100A (es) | Novedosos derivados de pirazolo-pirrolo-pirimidina como inhibidores de p2x3 | |
| AR112466A1 (es) | Complejo cosmético para la hidratación bioactiva, composición cosmética, uso y método | |
| ECSP20032718A (es) | Polimorfos | |
| CL2019001004A1 (es) | Derivados sustituidos de 6-(1h-pirazol-1-il)pirimidin-4-amina y usos de los mismos. | |
| CL2020002646A1 (es) | Composición para modular genes responsables de las funciones generales de la piel, que comprende al menos un extracto vegetal seleccionado de casearia sylvestris y schinus terebinthfolius y ácido hialurónico (divisional de la solicitud 03354-2018) | |
| CL2023001779A1 (es) | Composiciones de cannabidiol y usos de las mismas | |
| CL2022000317A1 (es) | Composición cosmética tópica, uso de la composición cosmética y máscara para aplicación facial | |
| CO2022001829A2 (es) | Composición farmacéutica acuosa de anticuerpo anti-pd1 prolgolimab y su uso | |
| CR20150641U (es) | Composiciones farmacéuticas | |
| BR112022001436A2 (pt) | Formas cristalinas de derivados de pirimidino-diazepina | |
| BR112022016428A2 (pt) | Uso de matriz extracelular placentária porcina descelularizada, estruturas porcinas e seus métodos de preparação | |
| CL2019003277A1 (es) | Composición cosmética de textura oleosa, uso y método para prevención y/o tratamiento de las señales de envejecimiento externo y del estrés cutáneo. |